Biblio Discovery — Demo Discovery Service

96 hasil untuk "Parast Layla"

Menampilkan 1–20 · 1,68 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Surrogate Marker Evaluation: A Tutorial Using R

    Parast, Layla

    Stat Med · 2025 · Inggris · PubMed Central

    The practice of using a surrogate marker to replace a primary outcome in clinical studies has become widespread. Typically, the primary outcome requires long-term patient follow-up, is expensive, or is invasive or burdensome on patients to measure, while the surrogate marker is not (or less so). Of…

  2. Artikel Jurnal Teks lengkap

    Assessing surrogate heterogeneity in real world data using meta-learners

    Knowlton Rebecca; Parast Layla

    Journal of Causal Inference, Vol. 14 No. 1 · 2026 · Inggris · DOAJ Scopus

    Surrogate markers are most commonly studied within the context of randomized clinical trials. However, the need for alternative outcomes also extends to real-world public health and social science research, where randomized trials are often impractical. While standard methods for evaluating…

    Juga tersedia di: PubMed Central

  3. Artikel Jurnal Teks lengkap

    Landmark Risk Prediction of Residual Life for Breast Cancer Survival

    Parast, Layla; Cai, Tianxi

    Stat Med · 2013 · Inggris · PubMed Central

    The importance of developing personalized risk prediction estimates has become increasingly evident in recent years. In general, patient populations may be heterogenous and represent a mixture of different unknown subtypes of disease. When the source of this heterogeneity and resulting subtypes of…

  4. Artikel Jurnal Teks lengkap

    Evaluation of longitudinal surrogate markers

    Agniel, Denis; Parast, Layla

    Biometrics · 2020 · Inggris · PubMed Central

    The use of surrogate markers to examine the effectiveness of a treatment has the potential to decrease study length and identify effective treatments more quickly. Most available methods to investigate the usefulness of a surrogate marker involve restrictive parametric assumptions and tend to focus…

  5. Artikel Jurnal Teks lengkap

    Group sequential testing of a treatment effect using a surrogate marker

    Parast, Layla; Bartroff, Jay

    Biometrics · 2024 · Inggris · PubMed Central

    The identification of surrogate markers is motivated by their potential to make decisions sooner about a treatment effect. However, few methods have been developed to actually use a surrogate marker to test for a treatment effect in a future study. Most existing methods consider combining surrogate…

  6. Artikel Jurnal Teks lengkap

    Flexible evaluation of surrogate markers with Bayesian model averaging

    Duan, Yunshan; Parast, Layla

    Stat Med · 2023 · Inggris · PubMed Central

    When long-term follow up is required for a primary endpoint in a randomized clinical trial, a valid surrogate marker can help to estimate the treatment effect and accelerate the decision process. Several model-based methods have been developed to evaluate the proportion of the treatment effect that…

  7. Artikel Jurnal Teks lengkap

    Robust evaluation of longitudinal surrogate markers with censored data

    Agniel, Denis; Parast, Layla

    J R Stat Soc Series B Stat Methodol · 2024 · Inggris · PubMed Central

    The development of statistical methods to evaluate surrogate markers is an active area of research. In many clinical settings, the surrogate marker is not simply a single measurement but is instead a longitudinal trajectory of measurements over time, e.g. fasting plasma glucose measured every 6…

  8. Artikel Jurnal Teks lengkap

    Efficient Testing Using Surrogate Information

    Knowlton, Rebecca; Parast, Layla

    Biom J · 2025 · Inggris · PubMed Central

    In modern clinical trials, there is immense pressure to use surrogate markers in place of an expensive or long-term primary outcome to make more timely decisions about treatment effectiveness. However, using a surrogate marker to test for a treatment effect can be difficult and controversial…

  9. Preprint Teks lengkap

    A Bayesian Critique of Rank-Based Methods for Surrogate Marker Evaluation

    Carlotti, Pietro; Parast, Layla

    arXiv · 2026 · Inggris · arXiv

    …the causal relationship between treatment and true clinical benefit. Parast et al. (2024) recently proposed a rank-based approach for evaluating surrogate markers, characterized by its nonparametric nature and minimal assumptions. While this method is useful in small-sample model-agnostic settings…

  10. Preprint Teks lengkap

    A Functional-Class Meta-Analytic Framework for Quantifying Surrogate Resilience

    Hsiao, Emily; Parast, Layla

    arXiv · 2026 · Inggris · arXiv

    A surrogate marker is a biomarker or other physical measurement used to replace a primary outcome in clinical trials to evaluate a treatment effect when the primary outcome of interest is costly, invasive, or takes a long time to observe. However, replacing a primary outcome with a surrogate can…

  11. Artikel Jurnal Teks lengkap

    Discussion of “A risk-based measure of time-varying prognostic discrimination for survival models,” by C. Jason Liang and Patrick J. Heagerty

    Parast, Layla; Rutter, Carolyn M.

    Biometrics · 2016 · Inggris · PubMed Central

    We congratulate Drs. Liang and Heagerty (L&H) for introducing a risk-based measure of time-varying discrimination for determining the value of predictors in time-to-event models. Their proposed hazard discrimination summary (HDS) is intuitive and its statistical properties are appealing. The…

  12. Artikel Jurnal Teks lengkap

    Landmark Estimation of Survival and Treatment Effects in Observational Studies

    Parast, Layla; Griffin, Beth Ann

    Lifetime Data Anal · 2016 · Inggris · PubMed Central

    …survival and improve power when testing for a treatment effect. Recently, Parast et al (2014) proposed a landmark estimation procedure for the estimation of survival and treatment effects in a randomized clinical trial setting and demonstrated that significant gains in efficiency and power could be…

  13. Artikel Jurnal Teks lengkap

    Quantifying the Bias due to Observed Individual Confounders in Causal Treatment Effect Estimates

    Parast, Layla; Griffin, Beth Ann

    Stat Med · 2020 · Inggris · PubMed Central

    It is often of interest to use observational data to estimate the causal effect of a target exposure or treatment on an outcome. When estimating the treatment effect, it is essential to appropriately adjust for selection bias due to observed confounders using, for example, propensity score…

  14. Artikel Jurnal Teks lengkap

    Dynamic landmark prediction for mixture data

    Garcia, Tanya P; Parast, Layla

    Biostatistics · 2019 · Inggris · PubMed Central

    In kin-cohort studies, clinicians want to provide their patients with the most current cumulative risk of death arising from a rare deleterious mutation. Estimating the cumulative risk is difficult when the genetic mutation status is unknown and only estimated probabilities of a patient having the…

  15. Artikel Jurnal Teks lengkap

    Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial

    Parast, Layla; Tian, Lu; Cai, Tianxi

    J Am Stat Assoc · 2014 · Inggris · PubMed Central

    In many studies with a survival outcome, it is often not feasible to fully observe the primary event of interest. This often leads to heavy censoring and thus, difficulty in efficiently estimating survival or comparing survival rates between two groups. In certain diseases, baseline covariates and…

  16. Artikel Jurnal Teks lengkap

    Meta-Analysis For Rare Events

    Cai, Tianxi; Parast, Layla; Ryan, Louise

    Stat Med · 2010 · Inggris · PubMed Central

    Meta analysis provides a useful framework for combining information across related studies and has been widely utilized to combine data from clinical studies in order to evaluate treatment efficacy. More recently, meta analysis has also been used to assess drug safety. However, because adverse…

  17. Artikel Jurnal Teks lengkap

    Evaluating Surrogate Marker Information using Censored Data

    Parast, Layla; Cai, Tianxi; Tian, Lu

    Stat Med · 2017 · Inggris · PubMed Central

    Given the long follow-up periods that are often required for treatment or intervention studies, the potential to use surrogate markers to decrease the required follow-up time is a very attractive goal. However, previous studies have shown that using inadequate markers or making inappropriate…

  18. Artikel Jurnal Teks lengkap

    Using a Surrogate Marker for Early Testing of a Treatment Effect

    Parast, Layla; Cai, Tianxi; Tian, Lu

    Biometrics · 2019 · Inggris · PubMed Central

    The development of methods to identify, validate and use surrogate markers to test for a treatment effect has been an area of intense research interest given the potential for valid surrogate markers to reduce the required costs and follow-up times of future studies. Several quantities and…

  19. Artikel Jurnal Teks lengkap

    Assessing the Value of a Censored Surrogate Outcome

    Parast, Layla; Tian, Lu; Cai, Tianxi

    Lifetime Data Anal · 2019 · Inggris · PubMed Central

    Assessing the potential of surrogate markers and surrogate outcomes for replacing a long term outcome is an active area of research. The interest in this topic is partly motivated by increasing pressure from stakeholders to shorten the time required to evaluate the safety and/or efficacy of a…